Sort
30,917 grants matching “tumor microenvironment”
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$371,226Katherine B Chiappinelli · George Washington University · R37 · FY2025 · CA
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
$371,216Ankur Singh · Cornell University · R33 · FY2017 · CA
Cathepsins in Malignant Progression
$371,183Bonnie F Sloane · Wayne State University · R01 · FY2007 · CA
Development of a Novel Nectin Targeting Antibody-drug Conjugate for Ovarian Cancer Therapy
$371,070Oliver Delgado · Resonant Therapeutics, Inc. · R43 · FY2024 · CA
Bioengineering approaches to map mechanotransduction in the living cell
$371,065Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2017 · GM
Project 3
$371,024Pasi A Janne · Dana-Farber Cancer Inst · P50 · FY2025 · CA
ER STRESS AS EARLY SENSOR OF NUTRIENT DEPRIVATION
$370,995J. Alan Diehl · University Of Pennsylvania · P01 · FY2007 · CA
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$370,994Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA
Adipocyte regulation of tumor survival in metastatic prostate cancer: new targets for therapy
$370,965Izabela Podgorski · Wayne State University · R01 · FY2024 · CA
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
$370,939David J Beebe · University Of Wisconsin-Madison · P50 · FY2022 · CA
Regulation of human dendritic cell activation
$370,935Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
USP18 in Cancer Development
$370,916Dong-Er Zhang · University Of California, San Diego · R01 · FY2023 · CA
USP18 in Cancer Development
$370,916Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · CA
In Vivo Oncogene-Induced Tumorigenesis and Escape
$370,903Lewis A Chodosh · University Of Pennsylvania · R01 · FY2019 · CA
Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression
$370,897Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2023 · CA
A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer
$370,878David Francis Kashatus · University Of Virginia · U54 · FY2024 · CA
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
$370,870Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2023 · CA
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
$370,870Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2022 · CA
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$370,800Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2019 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$370,782Everett Stone · University Of Texas At Austin · R01 · FY2022 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$370,782Everett Stone · University Of Texas At Austin · R01 · FY2023 · CA
Crosstalk between EGFR and TEAD Activity Directs Migration in Human Glioblastoma
$370,781Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
Crosstalk between EGFR and TEAD Activity Directs Migration in Human Glioblastoma
$370,781Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS
Crosstalk between EGFR and TEAD Activity Directs Migration in Human Glioblastoma
$370,781Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · NS
Crosstalk between EGFR and TEAD Activity Directs Migration in Human Glioblastoma
$370,781Nadejda Mincheva Tsankova · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS